• Addex, Indivior Forge $335M Addiction Disorder Tie-Up biospace
    January 04, 2018
    Indivior today announced that Indivior UK Limited has entered into a strategic collaboration with Addex Pharma S.A., a wholly-owned subsidiary of Addex Therapeutics (SIX: ADXN) ("Addex"), in the field of GABAB positive allosteric modulators
PharmaSources Customer Service